Spectrum (SPPI) Pops Higher Following Reacquisition of Apaziquone Rights
Tweet Send to a Friend
Spectrum Pharmaceuticals (Nasdaq: SPPI) shares are trading strong the session following a news release earlier of a notable acquisition.
This article: 480 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 480 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE